The antirheumatic drug leflunomide inhibits osteoclastogenesis by interfering with receptor activator of NF-kappa B ligand-stimulated induction of nuclear factor of activated T cells c1. (Q44800322)
Jump to navigation
Jump to search
scientific article published in March 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The antirheumatic drug leflunomide inhibits osteoclastogenesis by interfering with receptor activator of NF-kappa B ligand-stimulated induction of nuclear factor of activated T cells c1. |
scientific article published in March 2004 |
Statements
1 reference
The antirheumatic drug leflunomide inhibits osteoclastogenesis by interfering with receptor activator of NF-kappa B ligand-stimulated induction of nuclear factor of activated T cells c1. (English)
1 reference
Makoto Urushibara
1 reference
Hiroshi Takayanagi
1 reference
Takako Koga
1 reference
Sunhwa Kim
1 reference
Miho Isobe
1 reference
Yasuyuki Morishita
1 reference
Takumi Nakagawa
1 reference
Monika Löeffler
1 reference
Tatsuhiko Kodama
1 reference
Hisashi Kurosawa
1 reference
Tadatsugu Taniguchi
1 reference
1 March 2004
1 reference
1 reference
50
1 reference
3
1 reference
794-804
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference